Completed NA INTERVENTIONAL 1-arm NCT00928629

Audit and Screening Study to Determine the Prevalence of Peripheral Arterial Disease (ACHILLES)

Audit and Screening Study to Determine the Prevalence of Peripheral Arterial Disease. A Cross-sectional Multi-centre Clinical Study in Subjects With Cardiovascular Disease Risk Factors.

Sponsor: AstraZeneca

Conditions Peripheral Arterial Disease

Interventions Ankle-brachial index (ABI) Screening Test

Updated 5 times since 2017 Last updated: Nov 11, 2009 Started: Jun 30, 2009 Completion: Oct 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Peripheral Arterial Disease and is currently completed. AstraZeneca leads this study, which shows 5 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jun 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AstraZeneca
Pretium Pty Ltd

Data source: AstraZeneca

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aspley, Australia , Beulah Park, Australia , Booragoon, Australia , Bridgewater, Australia , Brighton, Australia , East Victoria Park, Australia , Edgecliff, Australia , Glenelg East, Australia , Hinchinbrook, Australia , Kingsford, Australia and 13 more locations